BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 30774485)

  • 1. Sjögren's syndrome and systemic lupus erythematosus: links and risks.
    Pasoto SG; Adriano de Oliveira Martins V; Bonfa E
    Open Access Rheumatol; 2019; 11():33-45. PubMed ID: 30774485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
    Ampélas JF; Wattiaux MJ; Van Amerongen AP
    Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyautoimmunity in systemic lupus erythematosus: secondary Sjogren syndrome.
    Sieiro Santos C; Moriano Morales C; Álvarez Castro C; Díez Alvarez E
    Z Rheumatol; 2023 Jan; 82(Suppl 1):68-73. PubMed ID: 34287668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sjögren Syndrome in Systemic Lupus Erythematosus: A Subset Characterized by a Systemic Inflammatory State.
    Ruacho G; Kvarnström M; Zickert A; Oke V; Rönnelid J; Eketjäll S; Elvin K; Gunnarsson I; Svenungsson E
    J Rheumatol; 2020 Jun; 47(6):865-875. PubMed ID: 31523050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review and meta-analysis of the epidemiology of polyautoimmunity in Sjögren's syndrome (secondary Sjögren's syndrome) focusing on autoimmune rheumatic diseases.
    Alani H; Henty JR; Thompson NL; Jury E; Ciurtin C
    Scand J Rheumatol; 2018 Mar; 47(2):141-154. PubMed ID: 28927315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies to Cytosolic 5'-Nucleotidase 1A in Primary Sjögren's Syndrome and Systemic Lupus Erythematosus.
    Rietveld A; van den Hoogen LL; Bizzaro N; Blokland SLM; Dähnrich C; Gottenberg JE; Houen G; Johannsen N; Mandl T; Meyer A; Nielsen CT; Olsson P; van Roon J; Schlumberger W; van Engelen BGM; Saris CGJ; Pruijn GJM
    Front Immunol; 2018; 9():1200. PubMed ID: 29922285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.
    Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM
    Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sicca symptoms and secondary Sjögren's syndrome in systemic lupus erythematosus: comparison with rheumatoid arthritis and correlation with disease variables.
    Gilboe IM; Kvien TK; Uhlig T; Husby G
    Ann Rheum Dis; 2001 Dec; 60(12):1103-9. PubMed ID: 11709451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjögren's syndrome.
    Alexander EL; Hirsch TJ; Arnett FC; Provost TT; Stevens MB
    J Rheumatol; 1982; 9(2):239-46. PubMed ID: 7097683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum 14-3-3η protein is associated with clinical and serologic features of Sjögren's syndrome in patients with systemic lupus erythematosus: a cross-sectional analysis.
    Hammam N; Gamal NM; Elzohri MH; Elsonbaty AM; Rashed AM; Eldaly ZH; Tarik D; Gheita TA
    Clin Rheumatol; 2020 Sep; 39(9):2603-2610. PubMed ID: 32206972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and immunological parameters of Sjögren's syndrome.
    Psianou K; Panagoulias I; Papanastasiou AD; de Lastic AL; Rodi M; Spantidea PI; Degn SE; Georgiou P; Mouzaki A
    Autoimmun Rev; 2018 Oct; 17(10):1053-1064. PubMed ID: 30103041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of salivary gland ultrasonography for secondary Sjögren syndrome in patients with systemic lupus erythematosus.
    Hammam N; Elzohri MH; Elsonbaty A; Eldaly ZH; Hammam O; Tarik D; Ibrahim HM; Gheita TA
    Lupus; 2022 Aug; 31(9):1045-1053. PubMed ID: 35514317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Th follicular cell subsets in minor salivary glands of patients with primary Sjögren's syndrome and systemic lupus erythematosus associated with Sjögren's syndrome.
    Hernandez-Molina G; Soto-Abraham V; Zamora-Legoff V; Furuzawa-Carballeda J
    Clin Exp Rheumatol; 2021; 39 Suppl 133(6):49-56. PubMed ID: 34596020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary Sjögren's syndrome with diffuse cystic lung changes developed systemic lupus erythematosus: a case report and literature review.
    Liu X; Li H; Yin Y; Ma D; Qu Y
    Oncotarget; 2017 May; 8(21):35473-35479. PubMed ID: 28415674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biosemantics guided gene expression profiling of Sjögren's syndrome: a comparative analysis with systemic lupus erythematosus and rheumatoid arthritis.
    Shah NR; Noll BD; Stevens CB; Brennan MT; Mougeot FB; Mougeot JC
    Arthritis Res Ther; 2017 Aug; 19(1):192. PubMed ID: 28818099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sjögren's syndrome associated with childhood-onset systemic lupus erythematosus].
    Iwata N; Mori M; Miyamae T; Ito S; Imagawa T; Yokota S
    Nihon Rinsho Meneki Gakkai Kaishi; 2008 Jun; 31(3):166-71. PubMed ID: 18587227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
    Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
    Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meibomian Gland Dysfunction in Primary and Secondary Sjögren Syndrome.
    Sullivan DA; Dana R; Sullivan RM; Krenzer KL; Sahin A; Arica B; Liu Y; Kam WR; Papas AS; Cermak JM
    Ophthalmic Res; 2018; 59(4):193-205. PubMed ID: 29627826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjögren's syndrome.
    Du Y; Su Y; He J; Yang Y; Shi Y; Cui Y; Luo C; Wu X; Liu X; Hu F; Ma X; Zheng L; Zhang J; Zuo X; Sheng Y; Wu L; Zhang X; Guo J; Li Z
    Ann Rheum Dis; 2015 Nov; 74(11):2070-5. PubMed ID: 24906639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of circulating anti-N-methyl-
    Tay SH; Fairhurst AM; Mak A
    Autoimmun Rev; 2017 Feb; 16(2):114-122. PubMed ID: 27988431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.